News for Sportradar Group AG (SRAD)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

MLB and Sportradar extend partnership for data distribution and fan experiences, boosting growth opportunities in sports betting and media markets...

Summary Sportradar Group AG (SRAD) and Major League Baseball (MLB) have announced a long-term extension and expansion of their partnership, effective from the 2

**media[535040]**

Shares of Sportradar Group AG (SRAD) fell 3.04% in mid-day trading on Jan 27. The stock reached an intraday low of $19.96, before recovering slightly to $20.1

We recently published a list of Jim Cramer Recently Shed Light on These 9 Stocks.

Sportradar Group (SRAD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Thumbs Up For This Stock On CNBC's “Mad Money Lightning Round,” Jim Cramer said Sportradar Group AG SRAD is speculative but he likes it. “I think you're ...

Summary Sportradar Group AG (SRAD), a leading global sports technology company, announced it will host an Investor Day in New York City on April 1, 2025. The ev

ST. GALLEN, Switzerland, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Sportradar Group AG ( SRAD) (”œSportradar” or the ”œCompany”), a leading global sports techno

Shares of Sportradar Group AG (SRAD) surged 3.56% in mid-day trading on Jan 14. The stock reached an intraday high of $19.75, before settling at $19.37, up

We recently compiled a list of the 12 Best Growth Stocks Under $25 to Buy Now. In this article, we are going to take a look at where Sportradar Group AG (NASDAQ:SRAD) stands against the other growth ...

Sportradar Group AG (SRAD) has announced a significant decline in suspicious matches across global sports in 2024, as detailed in their annual integrity report

**media[510429]**

Equities posted a strong quarter on the back of encouraging economic data and the anticipation of a series of interest rate cuts by the Federal Reserve.

NEW YORK, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC is pleased to announce our upcoming September conference schedule. On Wednesday,...

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes. Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.

The casino and gaming sector has outperformed the broad market over the last 52 weeks. Read more.